Alimera Sciences

^{, Nasdaq: ALIM}

Developing an injectable implant to treat eye diseases.

Industry: Health Care

First Day Return: 0.0%

ALIM

Developing an injectable implant to treat eye diseases.

IPO News for Alimera Sciences

Biotech Trius Therapeutics back on IPO calendar for week of July 26 07/14/10
Alimera Sciences quiet period ends May 31 05/26/10
Alimera Sciences prices IPO at $11.00, below the range 04/21/10

IPO Data
IPO Date	04/21/2010
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$72
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.alimerasciences.com
Headquarters	Alpharetta, GA, United States
Founded	2003
Employees at IPO	21

IPO News for Alimera Sciences

Biotech Trius Therapeutics back on IPO calendar for week of July 26 07/14/10
Alimera Sciences quiet period ends May 31 05/26/10
Alimera Sciences prices IPO at $11.00, below the range 04/21/10

Alimera Sciences (ALIM) Performance